MGCS is a heterogeneous group of nonmalignant MGs featuring two main characteristics: the presence of a clone, which is commonly associated with the secretion of an M-protein, and symptoms that can be related to the M-protein or to the clone itself by different mechanisms that do not include tumor burden. Here, MYOM2 is linked to neoplasm.